Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ARXS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsArxis closes $770M Omnetics acquisition, issues 13.4M shares for 3.1% dilution
Filed August 18, 2026 · Period ending August 18, 2026 · ~1 min read
Key Changes
-
high
Closed acquisition of Omnetics Connector for $770M enterprise value on Aug 17, 2026, issuing 13.4M Class A shares (~3.1% dilution) to sellers plus $8M cash escrow; shares subject to lockup provisions.
Item 2.01 verify on EDGAR → -
high
Combined Omnetics and MagCanica acquisitions valued at ~12x FY27 estimated adjusted EBITDA; individual contribution of each target to that EBITDA not disclosed.
Exhibit 99.1 view on EDGAR → -
medium
Omnetics manufactures proprietary high-reliability Micro-D-Sub and Nano-D-Sub connectors for defense, space, aerospace, and medical applications; will operate within Electronic Components segment.
Item 2.01 verify on EDGAR → -
medium
Unregistered equity sale of 13.4M shares to Omnetics sellers under Section 4(a)(2) exemption; details incorporated by reference from Item 2.01.
Item 3.02 verify on EDGAR →
Summary
Arxis closed its acquisition of Omnetics Connector Corporation on August 17, 2026, for an enterprise value of $770 million. The purchase was funded by issuing 13,351,964 shares of Class A common stock to Omnetics' former shareholders—representing approximately 3.1% dilution to existing holders—and $8 million deposited into cash escrow accounts.
The shares are subject to lockup provisions, limiting immediate selling pressure. Omnetics is a Minneapolis-based designer and manufacturer of proprietary high-reliability micro and nano connectors for defense, space, aerospace, and medical applications, and will operate within Arxis's Electronic Components segment.
The combined valuation multiple for both the Omnetics and MagCanica acquisitions is approximately 12 times estimated fiscal year 2027 adjusted EBITDA, though the individual contribution of each target to that EBITDA is not disclosed. Arxis highlights that its partnership with Arcline Investment Management provides institutional capabilities—market mapping, proprietary deal sourcing, underwriting discipline, and capital allocation expertise—that enhance its ability to identify and integrate acquisitions. The equity issuance was an unregistered sale under Section 4(a)(2) of the Securities Act.
Section-by-Section Diff
Event · Item 3.02 — Unregistered Sales of Equity Securities
Item 3.02 — Unregistered Sales of Equity Securities filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
The information included in Item 2.01 above is incorporated by reference into this Item 3.02.
The company disclosed an unregistered sale of equity securities under Item 3.02, with the transaction details incorporated by reference from Item 2.01 of this same 8-K. The filing does not provide the specifics of the transaction in the excerpt provided, as those details appear in the referenced Item 2.01 section. The disclosure includes a standard clarification that the 8-K itself is not an offer to sell securities.
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
As previously announced, the combined purchase price multiple with the MagCanica acquisition is approximately 12x FY27 estimated adjusted EBITDA.
The combined valuation multiple for both the Omnetics and MagCanica acquisitions is approximately 12 times estimated fiscal year 2027 adjusted EBITDA. This metric provides investors with a sense of the price paid relative to expected earnings power, though the individual contribution of each acquisition to that EBITDA is not disclosed.
Added in current filing · view on EDGAR →
Omnetics, headquartered in Minneapolis, Minnesota, is a leading designer and manufacturer of proprietary high-reliability Micro-D-Sub and Nano-D-Sub connectors and interconnect assemblies used in critical defense and space, commercial aerospace, and medical applications where size, weight, and reliability are mission critical. Omnetics will operate within Arxis' Electronic Components Segment.
Omnetics is a Minneapolis-based manufacturer of proprietary high-reliability micro and nano connectors for defense, space, aerospace, and medical applications. The company will be integrated into Arxis' Electronic Components Segment, expanding Arxis' presence in mission-critical connector markets where miniaturization and reliability are key differentiators.
Added in current filing · view on EDGAR →
The Omnetics acquisition reflects the differentiated value of the Arxis–Arcline partnership. Arcline provides Arxis with institutional capabilities that complement Arxis’ operating expertise, including research-driven market mapping, proprietary sourcing access, disciplined underwriting, and proven capital allocation expertise. These capabilities, which are difficult for a standalone strategic acquiror to replicate, expand Arxis’ addressable acquisition universe and strengthen its ability to acquire and integrate high-quality businesses with leading positions on long-duration platforms.
Arxis highlights that its partnership with Arcline Investment Management provides institutional capabilities—market mapping, proprietary deal sourcing, underwriting discipline, and capital allocation expertise—that enhance its ability to identify and integrate acquisitions. The company positions these capabilities as competitive advantages in pursuing high-quality businesses with durable market positions.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 19, 2026 · How we verify